| Field | Specification |
|---|---|
| Mfr No | |
| Clonality | |
| Host | |
| Immunogen | A synthesized peptide derived from human GSTA4 was used as the immunogen for the GSTA4 antibody. |
| Isotype | |
| Product Type | |
| Purity | |
| Reactivity | |
| Storage | |
| Target | |
| UniProt # |
Overview
GSTA4 Antibody / Glutathione S-transferase alpha 4 is an antibody targeting GSTA4. Host: Rabbit. Monoclonal. Clone: 31G31. Format: Liquid. Applications: WB.
Key elements and design rationale
- Target: GSTA4.
- Immunogen: A synthesized peptide derived from human GSTA4 was used as the immunogen for the GSTA4 antibody..
- Species reactivity: Human, Rat.
- Conjugate: Unconjugated (no label listed).
Biological background (from provided description)
GSTA4 antibody detects glutathione S-transferase alpha 4, an enzyme of the glutathione S-transferase (GST) family that catalyzes detoxification reactions. GSTA4 conjugates reduced glutathione to electrophilic compounds, facilitating their neutralization and removal.
Common research applications
- WB: relative abundance and band pattern assessment using appropriate controls.
Notes for experimental interpretation
- Account for isoforms, paralogs, and post-translational modifications when interpreting signal.
- Support specificity with biological controls (e.g., KO/KD where available) and technical controls (e.g., secondary-only/isotype).
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
